Literature DB >> 30108721

Orthoester functionalized N-guanidino derivatives of 1,5-dideoxy-1,5-imino-d-xylitol as pH-responsive inhibitors of β-glucocerebrosidase.

Alen Sevšek1, Javier Sastre Toraño1, Linda Quarles van Ufford1, Ed E Moret1, Roland J Pieters1, Nathaniel I Martin1.   

Abstract

Alkylated guanidino derivatives of 1,5-dideoxy-1,5-imino-d-xylitol bearing an orthoester moiety were prepared using a concise synthetic protocol. Inhibition assays with a panel of glycosidases revealed that one of the compounds prepared displays potent inhibition against human β-glucocerebrosidase (GBA) at pH 7.0 with IC50 values in the low nanomolar range. Notably, a significant drop in inhibitory activity is observed when the same compound is tested at pH 5.2. This pH sensitive activity is due to degradation of the orthoester functionality at lower pH accompanied by loss of the alkyl group. This approach provides a degree of control in tuning enzyme inhibition based on the local pH. Compounds like those here described may serve as tools for studying various lysosomal storage disorders such as Gaucher disease. In this regard, the most active compound was also evaluated as a potential pharmacological chaperone by assessing its effect on GBA activity in an assay employing fibroblasts from Gaucher patients.

Entities:  

Year:  2017        PMID: 30108721      PMCID: PMC6072142          DOI: 10.1039/c7md00480j

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  47 in total

1.  The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms.

Authors:  Richard A Steet; Stephen Chung; Brandon Wustman; Allan Powe; Hung Do; Stuart A Kornfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

Review 2.  A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity.

Authors:  Jian-Qiang Fan
Journal:  Biol Chem       Date:  2008-01       Impact factor: 3.915

3.  JAMA patient page. Gaucher disease.

Authors:  John L Zeller; Alison E Burke; Richard M Glass
Journal:  JAMA       Date:  2007-09-19       Impact factor: 56.272

4.  Rational design and synthesis of highly potent pharmacological chaperones for treatment of N370S mutant Gaucher disease.

Authors:  Guan-Nan Wang; Gabriele Reinkensmeier; Si-Wei Zhang; Jian Zhou; Liang-Ren Zhang; Li-He Zhang; Terry D Butters; Xin-Shan Ye
Journal:  J Med Chem       Date:  2009-05-28       Impact factor: 7.446

Review 5.  Iminosugars as therapeutic agents: recent advances and promising trends.

Authors:  Robert J Nash; Atsushi Kato; Chu-Yi Yu; George Wj Fleet
Journal:  Future Med Chem       Date:  2011-09       Impact factor: 3.808

6.  Identification and development of biphenyl substituted iminosugars as improved dual glucosylceramide synthase/neutral glucosylceramidase inhibitors.

Authors:  Amar T Ghisaidoobe; Richard J B H N van den Berg; Saleem S Butt; Anneke Strijland; Wilma E Donker-Koopman; Saskia Scheij; Adrianus M C H van den Nieuwendijk; Gerrit-Jan Koomen; Arnold van Loevezijn; Mark Leemhuis; Tom Wennekes; Mario van der Stelt; Gijsbert A van der Marel; Constant A A van Boeckel; Johannes M F G Aerts; Herman S Overkleeft
Journal:  J Med Chem       Date:  2014-10-17       Impact factor: 7.446

Review 7.  Pharmacological Chaperones: Design and Development of New Therapeutic Strategies for the Treatment of Conformational Diseases.

Authors:  Marino Convertino; Jhuma Das; Nikolay V Dokholyan
Journal:  ACS Chem Biol       Date:  2016-04-28       Impact factor: 5.100

8.  NG-hydroxyguanidines from primary amines.

Authors:  Nathaniel I Martin; Joshua J Woodward; Michael A Marletta
Journal:  Org Lett       Date:  2006-08-31       Impact factor: 6.005

9.  Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases.

Authors:  Elena M Sánchez-Fernández; José M García Fernández; Carmen Ortiz Mellet
Journal:  Chem Commun (Camb)       Date:  2016-04-25       Impact factor: 6.222

Review 10.  Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders.

Authors:  Giancarlo Parenti; Generoso Andria; Kenneth J Valenzano
Journal:  Mol Ther       Date:  2015-04-16       Impact factor: 11.454

View more
  2 in total

1.  Synthesis of modified 1,5-imino-d-xylitols as ligands for lysosomal β-glucocerebrosidase.

Authors:  Manuel Zoidl; Andreas Wolfsgruber; Michael Schalli; Seyed A Nasseri; Patrick Weber; Arnold E Stütz; Stephen G Withers; Tanja M Wrodnigg
Journal:  Monatsh Chem       Date:  2019-05-11       Impact factor: 1.451

2.  Thiol-ene "Click" Synthesis and Pharmacological Evaluation of C-Glycoside sp2-Iminosugar Glycolipids.

Authors:  Elena M Sánchez-Fernández; M Isabel García-Moreno; Raquel García-Hernández; José M Padrón; José M García Fernández; Francisco Gamarro; Carmen Ortiz Mellet
Journal:  Molecules       Date:  2019-08-08       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.